Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Change in Acquisitions & Divestments (2020 - 2026)

Nurix Therapeutics (NRIX) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $133.2 million as the latest value for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 4.34% to $133.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $611.5 million through Feb 2026, up 20.96% year-over-year, with the annual reading at $617.5 million for FY2025, 34.39% up from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $133.2 million at Nurix Therapeutics, down from $179.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $179.8 million in Q4 2025, with the low at $41.0 million in Q1 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $106.6 million, with a median of $99.8 million recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments crashed 30.23% in 2023, then skyrocketed 127.39% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $84.5 million in 2022, then fell by 9.33% to $76.6 million in 2023, then surged by 108.21% to $159.5 million in 2024, then increased by 12.73% to $179.8 million in 2025, then fell by 25.95% to $133.2 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $133.2 million, $179.8 million, and $156.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.